GAM
GSK icon

Gotham Asset Management’s GSK GSK Stock Holding History

Gotham Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,633
Closed -$200K – 1176
2021
Q4 		$200K Buy
+3,633
New +$189K 0.01% 1082
2021
Q3 		– Sell
-6,839
Closed -$340K – 1061
2021
Q2 		$340K Hold
6,839
– – 0.01% 799
2021
Q1 		$305K Buy
+6,839
New +$310K 0.01% 835
2020
Q1 		– Sell
-6,729
Closed -$395K – 1122
2019
Q4 		$395K Hold
6,729
– – 0.01% 873
2019
Q3 		$359K Buy
6,729
+25
+0.4% +$1.29K 0.01% 860
2019
Q2 		$335K Hold
6,704
– – 0.01% 920
2019
Q1 		$350K Buy
6,704
+28
+0.4% +$1.4K 0.01% 957
2018
Q4 		$319K Buy
6,676
+58
+0.9% +$2.86K 0.01% 854
2018
Q3 		$332K Hold
6,618
– – ﹤0.01% 818
2018
Q2 		$333K Sell
6,618
-15,715
-70% -$791K ﹤0.01% 762
2018
Q1 		$1.09M Sell
22,333
-1
-0% -$47 0.02% 600
2017
Q4 		$990K Buy
22,334
+580
+3% +$26.8K 0.01% 592
2017
Q3 		$1.1M Buy
21,754
+558
+3% +$28.3K 0.02% 596
2017
Q2 		$1.14M Buy
21,196
+882
+4% +$47K 0.02% 620
2017
Q1 		$1.07M Sell
20,314
-738
-4% -$37.4K 0.01% 655
2016
Q4 		$1.01M Buy
21,052
+825
+4% +$40.8K 0.01% 619
2016
Q3 		$1.09M Sell
20,227
-459
-2% -$25.2K 0.01% 591
2016
Q2 		$1.12M Sell
20,686
-20,379
-50% -$1.07M 0.01% 615
2016
Q1 		$2.08M Sell
41,065
-513
-1% -$25.6K 0.02% 568
2015
Q4 		$2.1M Buy
41,578
+417
+1% +$21.3K 0.02% 518
2015
Q3 		$1.98M Sell
41,161
-22,965
-36% -$1.2M 0.02% 542
2015
Q2 		$3.34M Sell
64,126
-2,736
-4% -$154K 0.03% 498
2015
Q1 		$3.86M Buy
66,862
+276
+0.4% +$15.8K 0.03% 458
2014
Q4 		$3.56M Sell
66,586
-184
-0.3% -$10.3K 0.03% 461
2014
Q3 		$3.84M Sell
66,770
-52
-0.1% -$3.19K 0.04% 449
2014
Q2 		$4.47M Buy
66,822
+60
+0.1% +$4.06K 0.06% 421
2014
Q1 		$4.46M Hold
66,762
– – 0.07% 380
2013
Q4 		$4.46M Buy
+66,762
New +$4.33M 0.11% 306

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Gotham Asset Management's GSK Position: Q1 2022 in Review

Gotham Asset Management sold out of GSK (GSK) in Q1 2022, closing a stake of 3,633 shares — an estimated $200K sold.

Gotham Asset Management first reported a position in GSK in Q4 2013 and held it in 28 quarters. The position peaked at $4.47M in Q2 2014. 929 funds tracked by Wall St. Rank hold GSK as of Q1 2022.

  • Gotham Asset Management reported no remaining GSK position as of Q1 2022 after selling out during the quarter.
  • Gotham Asset Management sold 3,633 GSK shares in Q1 2022, an estimated $200K.
  • Gotham Asset Management first reported a position in GSK in Q4 2013 and held it in 28 quarters.
  • Gotham Asset Management's GSK position peaked at $4.47M in Q2 2014.
  • 929 funds tracked by Wall St. Rank held GSK as of Q1 2022.

Based on Gotham Asset Management's 13F filing for Q1 2022, filed 16 May 2022.